A carregar...
Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes
AIMS/INTRODUCTION: To evaluate the efficacy and safety of once‐weekly (q.w.) extended‐release exenatide after switching from twice‐daily (b.i.d.) exenatide in patients with type 2 diabetes. MATERIALS AND METHODS: This was an investigator‐initiated, prospective, single‐arm, multicenter study. Individ...
Na minha lista:
| Publicado no: | J Diabetes Investig |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7078076/ https://ncbi.nlm.nih.gov/pubmed/31518492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13146 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|